Psyga
Caesarea, Israel · Founded 2021
- Headquarters
- Caesarea
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- cannasoul.co.il
- Last Round
- SeedApr 2024
- Rounds
- 1
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Psyga develops therapeutics derived from natural compounds, with a focus on psychedelic mushrooms. It uses Cannasoul’s proprietary analytical platform, data-driven approach, knowhow, and clinical trial framework to support active compound identification and development. Its work spans mushroom cultivation and extraction through the development of clinically approved formulations.
Summary
Psyga is a Biotech company based in Caesarea, Israel, founded in 2021. Its most recent funding was a Seed round in Apr 2024.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2024
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/psyga"><img src="https://indexed.vc/api/badge/company/psyga" alt="Psyga on Indexed.vc" width="260" height="76" /></a>